• In 2002, 8200 adults per 100 000 living in Alberta misused 1 or more prescription drugs in the preceding 12 months. Estimates suggest PDM has increased since that time.
Nevertheless to date, little epidemiologic information is available about the misuse of psychoactive prescription drugs in this country despite calls for a systematic assessment of this evolving problem. 15 Findings released from the Canadian Alcohol and Drug Use Monitoring Survey indicate that of the 28.4% of Canadians who used a psychoactive pharmaceutical drug in 2008, only 2% did so to get high. 16 There are additional reasons prescription drugs may be misused, including therapeutic effects (for example, to relieve pain or to sleep), to counteract the effects of other drugs, or to experiment; all of which may also be of clinical significance given they fall outside medically sanctioned use and may endanger public health. In our study, PDM was defined by prescription status (that is, medically sanctioned, compared with unsanctioned, use). Specifically, PDM was defined as use in larger amounts than prescribed, for a longer period than prescribed, or use without a physician's prescription. This definition casts a wider net, documenting the prevalence of PDM in the population as a whole, irrespective of motive. The goals of our study were to describe the prevalence of 12-month PDM in a populationbased Canadian sample and to examine the extent to which sociodemographic variables and other addictive behaviours were associated with this problem.
Method

Sample
A computer-aided telephone interview was administered to a random, representative sample of adults (n = 3511). Adults residing in private dwellings in Alberta were the target population. People living in group quarters (for example, rooming houses) and First Nations communities were excluded. Data were collected over a 2-month period in 2002. To participate, a respondent had to be a resident of the number called, be aged 18 years or older, and have the next birthday in the household. Households were selected using telephone numbers generated using random digit dialing. This process resulted in 6119 eligible screened numbers (that is, numbers that were not out of service, business, or fax numbers) from which 3511 respondents completed the full survey, 2553 refused, and 55 did not complete the survey in full, resulting in a response rate of 57.4%. Calls were made across a range of times to reduce the possibility of selection bias by employment status (9 AM to 9 PM on weekdays, 10 AM to 4 PM on Saturdays, and 2 PM to 8 PM on Sundays). Each household was contacted a maximum of 5 times. Sampling was stratified by region, with one-third drawn from Edmonton, Calgary, and the rest of the province. The mean interview length was 15 minutes. Our study received approval from the University of Alberta's Human Research Ethics Board and written informed consent was obtained from all participants. Data were weighted to correct for slight differences in the age and gender profile of respondents by region, compared with the Alberta 2001 census. All analyses were conducted on weighted data. Table 1 provides a description of the sample.
Measures
Prescription Drug Misuse
Four questions assessed PDM. Respondents were asked whether they had misused prescription opioids, sedatives, tranquilizers, or amphetamines in the 12 months preceding the interview, based on the following definition: use in larger amounts than prescribed, for a longer period than prescribed, or use without a physician's prescription. Respondents who indicated that they had misused prescriptions in a specific drug class were asked to list the prescriptions they had misused in the past year.
Illicit Drug Use and Dependence
Additional items assessed use of cannabis, illicit amphetamines, hallucinogens, solvents, cocaine or crack, and heroin in the preceding 12 months. The 7-item CIDI-SF was used to assess drug dependence. 17, 18 Respondents met criteria for dependence if they scored positively on 4 or more items. Respondents with no past-year drug use were coded noncases. Scores ranged from 0 to 7 (mean 0.18, SD 0.81). The internal consistency of scores was good (α = 0.85).
Alcohol Use and Dependence
Three alcohol variables were examined: 12-month alcohol use (yes or no), frequent binge drinking (yes or no), and alcohol dependence. Consistent with other studies, frequent binge drinkers were defined as those who reported 5 or more drinks on one occasion once a month or more in the preceding year.
19-21
The 7-item CIDI-SF for alcohol was used to assess alcohol dependence. 17, 21 Respondents met criteria for dependence if 
Abbreviations used in this article
Smoking
Respondents were asked how frequently they smoked cigarettes in the past 30 days. Respondents who selected every day were coded daily smokers and those who selected almost every day, some days, or half days were coded nondaily smokers. Respondents who selected not at all were coded nonsmokers.
Problem Gambling
Problem gambling was assessed using the PGSI; a 9-item subset of the Canadian Problem Gambling Index that measures problem gambling in population-based samples. 22 Problem gambling was defined by scores of 3 or more on the PGSI, and atrisk gambling by scores of 1 to 2. Respondents reporting no gambling in the past year were coded noncases. In our study, PGSI scores ranged from 0 to 27 (mean 0.43, SD 2.12) and internal consistency was excellent (α = 0.90).
Demographic Covariates
Sex and age were assessed across 5 categories, marital status across 3 categories, education across 4 categories, employment and income across 6 categories, and region across 3 categories.
Data Analyses
The point prevalence of PDM was measured by calculating the proportion of the total sample who reported past-year PDM at a single point in 2002. All measures of prevalence were calculated using the total sample in keeping with the standard definition of prevalence in the epidemiologic literature 23, 24 and to ensure an accurate measure of disease burden in Alberta for the specified time point.
The degree to which 2 sets of variables (sociodemographics and addictive behaviours) were correlated with PDM was examined using logistic regression, with a dichotomous measure of PDM as the outcome and 95% confidence intervals. First, a hierarchal logistic regression model was estimated for sociodemographic variables. Significant variables were retained, as were 3 nonsignificant variables (age, sex, and region) for comparison with other studies. Next, addictive behaviours were entered simultaneously as one block, with the exception of alcohol variables. Alcohol predictors were then entered in separate blocks to accommodate the hierarchical relation between them (that is, to binge drink, alcohol must be consumed, and binge drinking typically occurs before a person becomes alcohol dependent). Multicollinearity between independent variables was examined using VIFs. All potential interactions were tested using log-likelihood statistics. Missing data were handled using listwise deletion. All analyses were run using SPSS software, version 17.0 (SPSS Inc, Chicago IL). 
Results
Prevalence
The unadjusted 12-month prevalence of PDM was 8.6%. To reduce misclassification error, PDM cases were asked to list prescriptions misused. Thirteen cases reported misuse of over-the-counter drugs exclusively (for example, Nytol and caffeine pills) and were recoded noncases. The corrected prevalence of PDM was 8.2% overall; and 4.9%, 2.6%, 1.3%, and 0.8% for opiates, sedatives, amphetamines, and tranquilizers, respectively. Among PDMs, 86.3% misused prescriptions across 1 drug class, 10.9% across 2 drug classes, and 2.8% across 3 or more drug classes. Table 1 presents the prevalence of PDM by sociodemographic subgroup and Table  2 by subgroups reporting various forms of addictive behaviour. Although 16.2% of PDMs met criteria for drug dependence, it could not be discerned whether these people were illicit or prescription drug dependent from the data collected. Almost one-half of respondents who met criteria for drug dependence (48.9%) reported PDM in the past year, compared with 7.0% of respondents who were not drug dependent. Table 3 presents odds of 12-month PDM by sociodemographic subgroup using adjusted odds ratios and 95% confidence intervals. No 2-way interactions were significant. The odds of PDM were statistically similar across regions of Alberta, men and women, and a range of household income brackets. PDM odds were greater among young adults in models adjusted for sociodemographic characteristics. However, other addictive behaviours were also more prevalent among young adults, compared with adults aged 25 years and older (illicit drug use: 34.3%, compared with 9.3%; alcohol dependence: 10.6%, compared with 2.0%; and problem gambling: 6.6%, compared with 4.3%). Young adults were at no greater risk for PDM than older adults once other addictive behaviours were controlled in the model. This was also true for never-married respondents. In contrast, even in fully controlled models, respondents who reported their occupational status as disabled had 4 times greater odds of PDM than respondents employed full-or part-time. The odds of PDM also remained elevated for respondents with a high school diploma, relative to those with a post-secondary degree, and there was a trend toward significantly higher odds among respondents with some postsecondary training that may prove significant in larger samples. Interestingly, student status itself was a significant predictor of PDM in fully controlled models. Models controlling for sociodemographics alone underestimated the strength of this association. Adults who recorded their primary occupation as student had almost 2 times greater odds of PDM than adults employed full-or part-time; 70% of these students were young adults (mean 24 years, SD 7.8, range 18 to 55 years). Table 4 presents the odds of PDM by subgroups reporting various addictive behaviours. There was no evidence of multicollinearity across these variables (VIF 1.05 to 1.72) and no 2-way interactions were significant. All forms of addictive behaviour were positively associated with PDM in models adjusted for sociodemographics. There were striking reductions in the magnitude and significance of these associations once confounding between PDM and other addictive behaviours was controlled. In a fully controlled model, smoking was no longer associated with PDM suggesting this relation was based on associations between smoking and other addictive problems rather than PDM itself. In contrast, even in fully controlled models, problem gamblers had almost 3 times greater odds of PDM than nonproblem gamblers. Comparatively, the odds of PDM among problem gamblers was higher than any other addictive correlate measured in our study. Categories of drugs most frequently misused by problem gamblers matched that of the general population, but prevalence was considerably higher in each drug class (12.8% opiates, 8.5% sedatives, 5.5% stimulants, and 1.8% tranquilizers), odds of PDM were also higher among people using illicit drugs. Associations between PDM and cocaine use were stronger than cannabis or hallucinogen use (Table 4) . Respondents who engaged in both PDM and illicit drug use in the past year (n = 98) were more likely to misuse prescriptions across multiple drug categories than respondents who misused prescription drugs alone (24.2% compared with 8.4% [χ 2 = 13.37, df = 1, P < 0.001].
Correlates of Prescription Drug Misuse
Overestimation of the association between binge drinking and PDM in models controlling for sociodemographics may have been due in part to moderately sized correlations between binge drinking and illicit drug use (φ = 0.35, P < 0.001). Alcohol Overall, the prevalence of PDM among respondents meeting criteria for 1 or more of problem gambling, alcohol dependence, or illicit drug use was more than 3 times that of respondents without these addictive problems (18.8%, compared with 6.0%). Conversely, 43.7% of all respondents who misused prescription drugs met criteria for alcohol dependence, problem gambling, and (or) had used illicit drugs in the past year. Onethird of all respondents who misused prescription drugs had used illicit drugs in the past year, 12.4% were problem gamblers, and 12.0% were alcohol dependent.
Discussion
Our study examined the prevalence and correlates of PDM within a population-based sample of adults. Results indicate that in 2002, 8.2% or 8200 adults per 100 000 in Alberta had misused 1 or more prescription opiates, sedatives, amphetamines, or tranquilizers in the preceding 12 months. The overall prevalence of past-year opioid, sedative or tranquilizer, and stimulant misuse was 4.9%, 3.2%, and 0.8%, respectively. Among PDMs, 16.2% of respondents met criteria for illicit and (or) prescription drug dependence, compared with less than 1% of non-PDM respondents. Subpopulations at particular risk for PDM included disabled adults, adults with a high school diploma who had not pursued post-secondary studies, and adult students. Although the odds of PDM were particularly high among disabled adults, this finding was not surprising given they may use psychoactive prescriptions more frequently than the general population (for example, to control pain). 26 Disabled adults are also more likely to have underlying comorbidities such as depression that further increase the potential for PDM. 27, 28 Targeted interventions aimed at reducing PDM among disabled adults should not hinder the necessary medical management of pain in this subpopulation. While high school graduates were 70% more likely to misuse prescriptions than university graduates, high school dropouts displayed no greater odds for this problem. It may be that adults who have not completed high school are less likely to visit a doctor, request or receive medications, or less likely to report PDM than high school graduates. Given the monotonic associations between education and PDM documented in US studies 29, 30 further research is needed in Canada before more definitive conclusions can be made.
Confounding by other addictive behaviours masked higher odds of PDM among adult students. This association appears due in part to unique factors underlying the etiology of PDM among students, rather than factors typically shared by this subgroup, given these were controlled in the model (for example, young age or illicit drug use). There is evidence that US college students misuse prescriptions to relieve stress and improve concentration while studying, particularly in highly competitive academic environments. [31] [32] [33] Further research is needed to examine motives for PDM among Canadian students.
Contrary to previous studies, age, marital status, and sex were not significant predictors of PDM. 12, 14, 30, 33, 34 While young adults and never-married respondents displayed greater odds of PDM in initial models, these associations were no longer significant after other addictive behaviours were controlled, suggesting young adults and never-married respondents may have a higher propensity for addictive behaviours correlated with PDM, but no greater odds of PDM itself. As well, men had no greater odds of PDM than women. Using a definition of PDM matching our study, data derived from the 2001-2002 US NESARC study found lifetime PDM was more common among men across all categories of psychoactive prescription drugs. 13 Data from the 2003 US National Survey on Drug Use and Health found 12 month nonmedical opioid use (that is, without a prescription or for the feeling it caused) was also more common among men, while women were equally likely to misuse sedatives, tranquilizers, or stimulants. 35 Further research is needed to gain a better understanding of PDM by sex in Canada, including experiences that contribute to this problem across the life course. Clinical studies suggest affective stress and a history of sexual or physical abuse are risk factors for prescription opioid misuse in women, while criminal behaviour and associating with substance abusers are risk factors for men. [36] [37] [38] A population-based assessment of factors that precede PDM in Canada would make a significant contribution to our understanding of this problem.
Our study was among the first to examine associations between problem gambling and PDM in a population-based sample. The odds of PDM among problem gamblers was almost 3 times greater than nonproblem gamblers. Almost one-quarter of problem gamblers who misused prescriptions did so over 2 or more drug categories, increasing the likelihood for adverse consequences. Problem gamblers may be misusing prescriptions to cope with gambling losses, deal with gambling urges, to stay awake while gambling, or they may engage in both PDM and gambling to escape other life stressors. Further research is needed to shed more light on motives for PDM among problem gamblers.
While the NESARC study found lifetime smoking and lifetime PDM were associated in models adjusted for sociodemographics, 13 our study found additional control for other addictive behaviours negates this relation for 12-month behaviour. Findings suggest any association between smoking and PDM was a product of strong relations between smoking and other addictive behaviours rather than PDM itself. Future studies that separate PDM by motive (for example, to relieve pain or to get high) are needed to understand this relation in a more detailed way.
Despite the significant risk to increased morbidity and mortality, studies suggest the substance most frequently used in combination with prescription drugs is alcohol. 39 Our study found alcohol use was a risk factor for PDM, but this association was stronger for alcohol dependence than alcohol use alone. PDM among alcohol-dependent respondents frequently involved misuse across multiple prescription drug categories, increasing the risk for adverse consequences. Binge drinking, in contrast, did not increase the odds of PDM in fully controlled models. Similar to young adults and unmarried respondents, binge drinkers appeared to have a propensity for at-risk addictive behaviours highly correlated with PDM (for example, illicit drug use) rather than a specific proclivity for PDM itself.
Consistent with previous studies, illicit drug use was highly associated with PDM. 33, 35, 40 Almost one-quarter of respondents who used illicit drugs in the past year had also misused prescriptions in that time period. Associations between PDM and cocaine or crack use were stronger than cannabis or hallucinogen use.
More generally, many people who engage in addictive behaviours do so in complex ways that amplify the likelihood of PDM beyond the single odds ratios presented here. For example, single odds ratios do not take into account that most Our study had several limitations. Information about prescription drug use, motives for misuse, prescription drug dependence, and correlates of PDM in previous studies (for example, depression, anxiety, and physical illness) were not collected. Second, although research suggests sociodemographic factors may be uniquely associated with the specific drug class misused, 41 the sample size could not accommodate analyses by drug category. Third, the cross-sectional design precludes inferences about causation and temporal sequence. Finally, there may be response bias, owing to the relatively low response rate, use of self-report measures, and the use of telephone interviewing.
Conclusions
PDM was an important public health concern in Alberta in 2002. At that time, Canada reported the fourth highest per capita consumption of prescription narcotics in the world. 42 In 2009, Canada became the third highest per capita user, with estimates for prescription opiate misuse growing 24.3% between 2002 and 2005 alone. 43, 44 There is an urgent need for an ongoing assessment of this evolving problem. Despite its limited geographic locale, our work extends current knowledge about PDM in Canada and provides epidemiologic information that can be used to compare and complement future research in this area. 
